Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet | 23 | 2023 | 801 | 3.770 |
Why?
|
| Cohort Studies | 40 | 2024 | 1492 | 2.460 |
Why?
|
| Colorectal Neoplasms | 9 | 2022 | 441 | 2.380 |
Why?
|
| Risk Factors | 43 | 2022 | 3562 | 2.070 |
Why?
|
| Aged | 57 | 2024 | 6741 | 2.040 |
Why?
|
| Life Style | 9 | 2021 | 308 | 1.900 |
Why?
|
| Middle Aged | 59 | 2024 | 10129 | 1.720 |
Why?
|
| Prospective Studies | 23 | 2024 | 1378 | 1.700 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 905 | 1.690 |
Why?
|
| Prostatic Neoplasms | 10 | 2015 | 935 | 1.620 |
Why?
|
| Feeding Behavior | 11 | 2017 | 454 | 1.590 |
Why?
|
| Breast Neoplasms | 17 | 2021 | 1502 | 1.490 |
Why?
|
| Neoplasms | 7 | 2021 | 1103 | 1.440 |
Why?
|
| Mortality | 4 | 2017 | 145 | 1.380 |
Why?
|
| California | 18 | 2019 | 476 | 1.360 |
Why?
|
| Diet, Mediterranean | 4 | 2021 | 40 | 1.330 |
Why?
|
| Female | 60 | 2024 | 20969 | 1.230 |
Why?
|
| Male | 49 | 2024 | 20025 | 1.200 |
Why?
|
| Humans | 74 | 2024 | 37093 | 1.150 |
Why?
|
| Body Mass Index | 13 | 2023 | 854 | 1.140 |
Why?
|
| Hawaii | 23 | 2019 | 1929 | 1.140 |
Why?
|
| Proportional Hazards Models | 18 | 2022 | 441 | 1.120 |
Why?
|
| Inflammation | 3 | 2022 | 618 | 1.090 |
Why?
|
| Receptors, Estrogen | 7 | 2021 | 156 | 1.070 |
Why?
|
| Follow-Up Studies | 14 | 2022 | 974 | 1.070 |
Why?
|
| Vitamins | 5 | 2018 | 94 | 1.020 |
Why?
|
| Weight Gain | 4 | 2021 | 136 | 1.010 |
Why?
|
| Dietary Supplements | 4 | 2011 | 208 | 0.900 |
Why?
|
| United States | 18 | 2024 | 4223 | 0.900 |
Why?
|
| Alcohol Drinking | 4 | 2019 | 519 | 0.870 |
Why?
|
| Exercise | 6 | 2022 | 613 | 0.850 |
Why?
|
| Vitamin D | 3 | 2010 | 196 | 0.790 |
Why?
|
| Smoking | 6 | 2021 | 940 | 0.770 |
Why?
|
| Dietary Fats | 4 | 2011 | 119 | 0.750 |
Why?
|
| Menopause | 4 | 2016 | 56 | 0.740 |
Why?
|
| Postmenopause | 5 | 2021 | 128 | 0.730 |
Why?
|
| Isoflavones | 3 | 2014 | 129 | 0.730 |
Why?
|
| Receptors, Progesterone | 4 | 2021 | 81 | 0.730 |
Why?
|
| Obesity | 10 | 2023 | 1067 | 0.680 |
Why?
|
| Caffeine | 1 | 2018 | 28 | 0.630 |
Why?
|
| Nutrition Policy | 4 | 2008 | 70 | 0.620 |
Why?
|
| Calcium, Dietary | 3 | 2007 | 85 | 0.610 |
Why?
|
| Coffee | 1 | 2017 | 20 | 0.590 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 12 | 0.590 |
Why?
|
| Drinking | 1 | 2017 | 38 | 0.590 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 358 | 0.570 |
Why?
|
| Health Status Indicators | 1 | 2017 | 75 | 0.570 |
Why?
|
| Antioxidants | 3 | 2013 | 416 | 0.560 |
Why?
|
| Aspirin | 1 | 2016 | 49 | 0.550 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 41 | 0.550 |
Why?
|
| Dietary Fiber | 1 | 2016 | 47 | 0.550 |
Why?
|
| Risk Assessment | 3 | 2016 | 753 | 0.550 |
Why?
|
| Central Nervous System Stimulants | 1 | 2018 | 174 | 0.540 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 664 | 0.540 |
Why?
|
| Forecasting | 1 | 2016 | 128 | 0.540 |
Why?
|
| Acculturation | 4 | 2005 | 188 | 0.530 |
Why?
|
| Overweight | 2 | 2023 | 247 | 0.520 |
Why?
|
| Diet Surveys | 7 | 2022 | 101 | 0.510 |
Why?
|
| Minerals | 4 | 2008 | 47 | 0.500 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 186 | 0.500 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 251 | 0.500 |
Why?
|
| Case-Control Studies | 8 | 2016 | 1130 | 0.460 |
Why?
|
| Medicare | 3 | 2024 | 195 | 0.440 |
Why?
|
| Carotenoids | 2 | 2013 | 70 | 0.430 |
Why?
|
| Incidence | 9 | 2020 | 922 | 0.430 |
Why?
|
| Vegetables | 2 | 2013 | 147 | 0.430 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 63 | 0.430 |
Why?
|
| Adult | 18 | 2021 | 11712 | 0.420 |
Why?
|
| Fruit | 2 | 2013 | 173 | 0.420 |
Why?
|
| Fatty Acids | 2 | 2014 | 127 | 0.420 |
Why?
|
| Meat | 3 | 2009 | 43 | 0.410 |
Why?
|
| Prognosis | 6 | 2021 | 739 | 0.400 |
Why?
|
| Zinc | 1 | 2012 | 128 | 0.390 |
Why?
|
| Energy Intake | 3 | 2008 | 170 | 0.380 |
Why?
|
| Dairy Products | 2 | 2007 | 35 | 0.380 |
Why?
|
| Nutritional Requirements | 3 | 2008 | 36 | 0.350 |
Why?
|
| Phytoestrogens | 1 | 2009 | 38 | 0.340 |
Why?
|
| Genistein | 1 | 2009 | 42 | 0.340 |
Why?
|
| Cause of Death | 3 | 2018 | 156 | 0.320 |
Why?
|
| Sex Factors | 3 | 2019 | 898 | 0.320 |
Why?
|
| Fabaceae | 1 | 2008 | 27 | 0.320 |
Why?
|
| Socioeconomic Factors | 3 | 2020 | 1067 | 0.310 |
Why?
|
| Logistic Models | 6 | 2016 | 923 | 0.280 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 31 | 0.280 |
Why?
|
| Nutritional Status | 2 | 2007 | 116 | 0.270 |
Why?
|
| Los Angeles | 5 | 2018 | 380 | 0.270 |
Why?
|
| Chronic Disease | 2 | 2007 | 484 | 0.260 |
Why?
|
| Age Distribution | 2 | 2019 | 225 | 0.260 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 82 | 0.250 |
Why?
|
| Korea | 4 | 2005 | 43 | 0.250 |
Why?
|
| Apolipoproteins E | 2 | 2022 | 129 | 0.240 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2004 | 18 | 0.240 |
Why?
|
| Eating | 2 | 2022 | 166 | 0.240 |
Why?
|
| Residence Characteristics | 2 | 2017 | 322 | 0.240 |
Why?
|
| Young Adult | 9 | 2021 | 4268 | 0.230 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 47 | 0.230 |
Why?
|
| Odds Ratio | 6 | 2016 | 534 | 0.210 |
Why?
|
| Soy Foods | 3 | 2014 | 60 | 0.210 |
Why?
|
| Sex Distribution | 2 | 2019 | 215 | 0.200 |
Why?
|
| Registries | 3 | 2015 | 335 | 0.190 |
Why?
|
| Body Weights and Measures | 1 | 2021 | 22 | 0.190 |
Why?
|
| Gonadal Hormones | 1 | 2021 | 6 | 0.190 |
Why?
|
| Mothers | 1 | 2003 | 181 | 0.190 |
Why?
|
| Nutrition Assessment | 2 | 2013 | 79 | 0.190 |
Why?
|
| Adiposity | 1 | 2022 | 154 | 0.190 |
Why?
|
| Health Behavior | 2 | 2019 | 537 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 149 | 0.180 |
Why?
|
| Endometrial Neoplasms | 1 | 2021 | 66 | 0.180 |
Why?
|
| Reproductive History | 2 | 2021 | 19 | 0.180 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 885 | 0.170 |
Why?
|
| Alcoholic Beverages | 1 | 2019 | 15 | 0.170 |
Why?
|
| Mammography | 2 | 2013 | 188 | 0.170 |
Why?
|
| Aged, 80 and over | 8 | 2022 | 2379 | 0.160 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 2721 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 312 | 0.140 |
Why?
|
| SEER Program | 3 | 2015 | 91 | 0.140 |
Why?
|
| Multiple Myeloma | 1 | 2016 | 39 | 0.130 |
Why?
|
| Age Factors | 3 | 2018 | 1033 | 0.130 |
Why?
|
| Neoplasm Staging | 2 | 2013 | 275 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 121 | 0.130 |
Why?
|
| Menarche | 1 | 2015 | 13 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2017 | 643 | 0.130 |
Why?
|
| Body Fat Distribution | 1 | 2015 | 24 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2015 | 90 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2016 | 238 | 0.120 |
Why?
|
| Adolescent | 5 | 2015 | 5363 | 0.120 |
Why?
|
| beta Carotene | 1 | 2013 | 11 | 0.110 |
Why?
|
| Xanthophylls | 1 | 2013 | 15 | 0.110 |
Why?
|
| Risk | 3 | 2014 | 267 | 0.110 |
Why?
|
| Folic Acid | 1 | 2013 | 46 | 0.110 |
Why?
|
| Vitamin E | 1 | 2013 | 61 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 111 | 0.110 |
Why?
|
| Survival Rate | 1 | 2013 | 311 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 39 | 0.110 |
Why?
|
| Body Size | 1 | 2012 | 32 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2022 | 171 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2012 | 325 | 0.100 |
Why?
|
| Child | 3 | 2015 | 3131 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 935 | 0.100 |
Why?
|
| Prevalence | 3 | 2016 | 1455 | 0.090 |
Why?
|
| Educational Status | 2 | 2018 | 313 | 0.090 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2009 | 27 | 0.090 |
Why?
|
| Heterocyclic Compounds | 1 | 2009 | 21 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2009 | 39 | 0.080 |
Why?
|
| Body Height | 1 | 2009 | 53 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2009 | 161 | 0.080 |
Why?
|
| Comorbidity | 1 | 2011 | 623 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2008 | 111 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2007 | 59 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 3 | 2017 | 146 | 0.070 |
Why?
|
| Japan | 1 | 2008 | 305 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2008 | 381 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2005 | 81 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2005 | 117 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 107 | 0.060 |
Why?
|
| Cholesterol, Dietary | 1 | 2004 | 10 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 485 | 0.060 |
Why?
|
| Dietary Carbohydrates | 1 | 2004 | 31 | 0.060 |
Why?
|
| Sodium, Dietary | 1 | 2004 | 27 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1039 | 0.060 |
Why?
|
| Food Preferences | 1 | 2003 | 73 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 251 | 0.050 |
Why?
|
| Social Class | 2 | 2017 | 247 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 149 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2013 | 149 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 220 | 0.050 |
Why?
|
| Phenotype | 1 | 2022 | 689 | 0.040 |
Why?
|
| Marital Status | 1 | 2018 | 40 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 89 | 0.040 |
Why?
|
| Parity | 1 | 2015 | 46 | 0.030 |
Why?
|
| Stearic Acids | 1 | 2014 | 5 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2014 | 14 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2014 | 16 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2014 | 12 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 34 | 0.030 |
Why?
|
| Animals | 2 | 2009 | 15081 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2015 | 113 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2015 | 133 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 275 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2013 | 49 | 0.030 |
Why?
|
| Leisure Activities | 1 | 2013 | 33 | 0.030 |
Why?
|
| Body Composition | 1 | 2012 | 162 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 1549 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 434 | 0.020 |
Why?
|
| Milk | 1 | 2009 | 50 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1742 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 583 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 767 | 0.020 |
Why?
|